Baird raised the firm’s price target on Blueprint Medicines (BPMC) to $135 from $127 and keeps an Outperform rating on the shares. The firm ...

Oppenheimer analyst Matthew Biegler says Blueprint Medicines (BPMC) reported Q4 Ayvakit sales of $146M, in line with consensus but below the ...

According to Europol, most of the trade in counterfeit medicines takes place on social media, online marketplaces and the dark net. “Organized crime networks sell substandard, mislabeled or ...

Medicines may be processed, packaged, sold, and resold multiple times before reaching consumers. For regulators, it can be difficult to ensure the safety of drugs before they hit pharmacy shelves.

An illustration of a magnifying glass. An illustration of a magnifying glass.

Ahmedabad: The Kumbh isn't just a religious gathering but a blueprint for sustainable civilization, a testament to cultural authenticity and a living example of tradition adapting to modernity ...

15 analysts have expressed a variety of opinions on Blueprint Medicines (NASDAQ:BPMC) over the past quarter, offering a diverse set of opinions from bullish to bearish. In the table below ...

Blueprint Medicines Corporation (Nasdaq: BPMC) today provided a 2025 corporate outlook and strategy for continued growth leveraging the company's proven R&D and commercial capabilities.

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include avapritinib, ...

Their work, now published in Nature Chemistry, could lead to better medicines and new tools in synthetic biology. Water is everywhere. It's the unsung hero of protein function, but it's often ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...